Research

Energy balance

Tirzepatide treatment resulted in a mean weight loss of 9.94 ± 4.8 kg and a percentage weight loss of 9.7 ± 4.8 % after 4 months.

Tirzepatide can be an effective option for weight management in patients with obesity.

StrongSupportsmedium confidence
Weight loss (9.94 ± 4.8 kg) and percentage weight loss (9.7 ± 4.8 %) were similar to those reported in SURMOUNT-1.
Jorge Blanco Anesto et al. · Nutrición Hospitalaria · 2026

Why this rating

Based on the analysis of real-world data from a defined patient group.

Source

Tirzepatide in real-world clinical practice: changes in body composition and muscle function in patients with obesity

Jorge Blanco Anesto et al. · Nutrición Hospitalaria · 2026

DOI 10.20960/nh.06592

cohort · n=52
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →